People with diabetes are at risk for life-threatening blood vessel
diseases. Left untreated, these conditions can lead to complications
such as heart attack, stroke and amputation.
For the study, researchers examined data on almost 34,000 people
with diabetes who initially had employer-sponsored health plans with
deductibles of $500 or less - but then their employers switched to
offering only plans with deductibles of $1,000 or more. The study
team also looked at a comparison group of almost 295,000 workers
with diabetes who consistently had deductibles of $500 or less.
Before the first group switched to higher deductible health plans,
there were no meaningful differences between the groups in how long
patients waited to get care for complications that can be
life-threatening without timely treatment, the study found.
But over the four years after some employers switched to offering
only high-deductible plans, the patients on these plans waited an
average of 1.5 months longer than people on low-deductible plans to
seek care for new symptoms of cardiovascular complications
associated with diabetes, 1.9 months longer for diagnostic tests and
3.1 months longer for medical procedures to treat these
complications.
"We found that delays or reductions in care for cardiovascular
disease persisted over a relatively long follow-up and occurred even
for services that are used for life-threatening conditions," said
study leader Dr. Frank Wharam of Harvard Medical School and Harvard
Pilgrim Health Care Institute in Boston.
An increasing proportion of Americans, including people with
diabetes, have high-deductible health insurance plans requiring them
to pay up to about $1,000 to $7,000 out-of-pocket per year if they
use healthcare services, researchers note in the Annals of Internal
Medicine. But studies to date haven't offered a clear picture of how
this added cost might impact healthcare utilization for people with
diabetes.
The study can't prove whether or how costs might have influenced how
long patients waited to get any needed exams, lab tests or
treatments.
But it's likely that money played a role because everyone in the
study had diabetes with similar risks of cardiovascular
complications, Wharam said by email.
[to top of second column] |
"We can speculate that diabetes patients' knowledge of the high cost
of care, and a desire to save money, led to these patterns," Wharam
said.
All of the patients in the study had employer-sponsored health
insurance provided by a single large health insurance company in the
U.S. between 2003 and 2012, and their employers did not offer more
than one option for insurance in any given year.
People who switched to high-deductible plans were 6 percent less
likely to seek care for the first new major symptom of complications
during the study, such as chest or leg pain. They were also 9
percent less likely to get the first diagnostic test they needed and
9 percent less likely to get procedures to treat these
complications.
Compared to the people who remained in low-deductible plans
throughout the study, those who switched to higher-deductible plans
had their out-of-pocket health costs increase by an average of 43
percent to 53 percent per year.
The research team couldn't verify why patients may have chosen to
wait for needed care, making it impossible to prove that increased
costs were partially or completely responsible, the authors note.
"I am not aware of any rigorous studies that ask about motives and
thought processes, but the economic model would suggest that a
person who would have to pay more would delay care for mild symptoms
that might resolve on their own," said Mark Pauly of the Wharton
School and the Perelman School of Medicine at the University of
Pennsylvania in Philadelphia.
"Someone whose care is free because insurance covers it would be
more likely to seek care at the first sign of a symptom," Pauly,
author of an accompanying editorial, said by email.
SOURCE: https://bit.ly/2qUsCyw and https://bit.ly/2Q6vTcf Annals of
Internal Medicine, online November 19, 2018.
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |